In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, ...

In the second part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

Analysis compares care quality and efficiency within physician groups that treat Medicare Advantage patients under at-risk ...

2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials. In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer at ...

In the first part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses ...

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply ...

In the final part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, describes what meaningful ...

Advanced tracking technologies like RFID improve visibility and reduce risks. Continuous, real-time monitoring enables more ...

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based ...

Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping ...